| Tumor Type | # Completed | Percentage |
|---|---|---|
| OV | 16 | 84% |
| GBM | 16 | 84% |
| UCEC | 15 | 79% |
| COADREAD | 14 | 74% |
| LUSC | 11 | 58% |
| LUAD | 11 | 58% |
| BRCA | 11 | 58% |
| KIRC | 10 | 53% |
| KIRP | 9 | 47% |
| LGG | 8 | 42% |
| STAD | 5 | 26% |
| THCA | 3 | 16% |
| PAAD | 3 | 16% |
| LIHC | 3 | 16% |
| HNSC | 3 | 16% |
| CESC | 3 | 16% |
| BLCA | 3 | 16% |
| PRAD | 2 | 11% |
| LAML | 2 | 11% |
| LNNH | 0 | 0% |
| DLBC | 0 | 0% |